| Independent Reports (Showing 1 to 10 of 15) |
Release Date ![[down]](http://us.i1.yimg.com/us.yimg.com/i/fi/down.gif) |
Contributor |
Author |
Title |
Pages |
Price |
More Info |
| 9-Feb-10 | New Constructs, LLC | N/A | NTII: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings | 19 | $10 | View Abstract |
| 8-Feb-10 | Plunkett Research, Ltd. | Jack W. Plunkett | Biotechnology & Genetics Industry Market Research and Competitive Analysis 2010 | 569 | $299 | View Abstract |
| 8-Feb-10 | Plunkett Research, Ltd. | Jack W. Plunkett | Biotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary) | 71 | $199 | View Abstract |
| 6-Feb-10 | Reuters Investment Profile | N/A | Neurobiological Technologies Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. | 12 | $20 | View Abstract |
| 5-Feb-10 | Ford Investor Services, Inc. | N/A | Value Graph: NEUROBIOLOG TECH -- NTII | 1 | $4 | View Abstract |
| 5-Feb-10 | Ford Investor Services, Inc. | N/A | Industry Value Graph: ENCO , ISPH , NTII , POZN , SUPG -- DRUGS | 3 | $4 | View Abstract |
| 31-Jan-10 | Wright Reports | N/A | Wright Investors Service Comprehensive Report for Neurobiological Technologies, Inc. | 41 | $65 | View Abstract |
| 13-Jan-10 | Life Science Analytics | Life Science Analytics | NeuroBioTex Inc.-Company Report | 4 | $85 | View Abstract |
| 30-Mar-09 | ValuEngine, Inc. | N/A | ValuEngine Detailed Valuation Report for NTII | 13 | $25 | View Abstract |
| 29-Mar-09 | PriceTarget Research, Inc. | N/A | Biotechnology Intelligence Monitor: overall outlook STRONG - 25 new Leaders; 12 new Laggards. | 52 | $20 | View Abstract |